Candace S. Johnson
About
In The Last Decade
Candace S. Johnson
175 papers receiving 7.9k citations
Hit Papers
Peers
Comparison fields: 5 of 153
- Pathology and Forensic Medicine 3.6k
- Molecular Biology 2.9k
- Oncology 1.8k
- Genetics 1.6k
- Pulmonary and Respiratory Medicine 1.0k
Countries citing papers authored by Candace S. Johnson
This map shows the geographic impact of Candace S. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Candace S. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Candace S. Johnson more than expected).
Fields of papers citing papers by Candace S. Johnson
This network shows the impact of papers produced by Candace S. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Candace S. Johnson. The network helps show where Candace S. Johnson may publish in the future.
Co-authorship network of co-authors of Candace S. Johnson
This figure shows the co-authorship network connecting the top 25 collaborators of Candace S. Johnson. A scholar is included among the top collaborators of Candace S. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Candace S. Johnson. Candace S. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 29 | |
| 3 | 49 | |
| 4 | 17 | |
| 5 | 17 | |
| 6 | Do Masculinity and Perceived C ondom Barriers Predict Heterosexual HIV Risk Behaviors among Black Substance Abusing Men | 4 |
| 7 | 26 | |
| 8 | 33 | |
| 9 | 52 | |
| 10 | 78 | |
| 11 | 17 | |
| 12 | 36 | |
| 13 | 77 | |
| 14 | 67 | |
| 15 | 48 | |
| 16 | Enhancing Retention Through a Condensed Trauma-integrated Booster Intervention for Women with Chemical Dependence | 5 |
| 17 | 41 | |
| 18 | 16 | |
| 19 | A phase I and pharmacokinetic (PK) study of intravenous (IV) calcitriol and gefitinib assessing EGFR pharmacodynamic (PD) interactions through serial skin biopsies | 1 |
| 20 | 54 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.